Oppie gets it. To be exponential something needs to double every period of time. LOL
DTC never begins before 6 months after a launch. Further, nothing would have killed a broad push sooner than having interested patients talk to uneducated endos who tell them that inhaled insulin doesn't work. The shadow of Exubera is still pretty long. The awareness campaign amongst doctors needs to happen quickly but that does feel like the right strategy to me.
You're lying. You can erase history but not memories. You have explicitly said you'd sell after an RS/Up-list as you expect the stock to slide for a while. Ya'caught.
The biggest label concern is for those who smoke. If you smoke as someone with diabetes you are taking your life into your own hands. Not a huge population of smokers at all anyone in the US.
It's a great idea but dems and reps both won't vote for that because they'd lose Wall Street support.
That's nothing. Best case scenario you make an extra 3 cents a share. Worst case you cap your earnings if the uptrend resumes. Nothing in the technicals make this look like a top. So it's risky.
Sell call options with a time value. Selling Jan 16 or even 17 calls can be good because even if it ends up in the money you've made money on the time value. Get it?
Selling the calls makes sense because profit is pretty much guaranteed. Offering that many puts at that strike price is unusual though. Also notice only a nibble. If sentiment were bearish it would be a fine buy with pretty much no time premium.
The put seller is betting on rising prices and may well be the call seller too in which case someone believes this is going to run further but maybe short of $10 by June.
That's not this. Selling calls at $10 makes sense but almost an equal amount of options are available for sale as puts. The seller would profit if the share price lands between here and $10-14. Highest profitability would be just over or at $10.
You are trying to claim victory but that's laughable. 3-5% down after 33% up. Lol.
People enjoyed 20+% gains these last three days. A portion of people will have sold to lock in profits. A good portion of those should be buying back in.
The chances of tomorrow being a brutal down on news day is lower when there is a tidy consolidation today.
Practically, there will not be a buyout before SNY/MDT announce a 20% stake in the company. If they try to buy out without a stake then the share price will end up as way too high way too fast.
Interesting. And what's your theory on BAC loading up on call options? Is that also a way to create new bagholders? Sounds like the only bagolders are shorts who started shorting under $4
Of thousands of patients as reported by doctors, and toxicity remains low, then we have a mammoth winner on our hands. Ideally the FDA label changes, but even if not, it will be hard for doctors to ignore it when all of their Afrezza patients come in several pounds lighter. People don't like sticking needles in themselves, but more than that I have to imagine they sure love losing weight.